Figure 1: Overall survival of patients with IDH-mutant astrocytoma WHO 2 or 3 stratified according to initial treatment after histological sampling. WS, wait-and-scan; TMZ, temozolomide; RT, radiotherapy
Figure 1: Overall survival of patients with IDH-mutant astrocytoma WHO 2 or 3 stratified according to initial treatment after histological sampling. WS, wait-and-scan; TMZ, temozolomide; RT, radiotherapy